Investing
Airbnb, Centerpoint, Editas and More Friday Afternoon Analyst Calls
Published:
With the trading day more than halfway over, the broad markets recovered slightly from Thursday’s downturn, with the exception of the Dow Jones industrial average. The S&P 500 and Nasdaq each posted decent gains after having been negative at least once earlier in the day.
24/7 Wall St. is looking at some big analyst calls that we have seen so far on Friday. We have included the most recent analyst call on each stock, as well as a recent trading history and the consensus targets among analysts.
For those that might have missed it, 24/7 Wall St. had an earlier round of analyst calls on Friday that included AIG, Best Buy, Carvana, Dell, HP, Monster and more.
Airbnb Inc. (NASDAQ: ABNB) was reiterated as Buy and its price target was raised to $270 from $175 at Canaccord Genuity. Shares traded near $210 on Friday. The 52-week trading range is $121.50 to $219.94. The consensus price target is $163.56.
Agios Pharmaceuticals Inc. (NASDAQ: AGIO) was downgraded by SBV Leerink to Market Perform from Outperform. Shares were trading below $48. The stock has changed hands within a 52-week range of $46.60 to $58.93, and it has a consensus price target of $65.60.
Centerpoint Energy Inc. (NYSE: CNP) was downgraded by Evercore ISI to In-Line from Outperform. The stock was last seen near $20 a share. The 52-week trading range is $11.58 to $25.39, and the consensus price target is $24.58.
Denali Therapeutics Inc. (NASDAQ: DNLI) was reiterated as Buy and its price target was raised to $95 from $80 at H.C. Wainwright. The shares traded near $69. The 52-week range is $12.39 to $93.94, and analysts have a consensus price target of $78.78.
Editas Medicine Inc. (NASDAQ: EDIT) was downgraded by Truist Securities from Buy to Hold with a $45 price target. The stock traded near $44 on Friday, in a 52-week range of $14.01 to $99.95. It has a consensus price target of $54.83.
Lending Tree Inc. (NASDAQ: TREE) was downgraded by Northland Capital to Underperform from Market Perform and its price target was cut to $250 from $315. The consensus price target is $361.25. Shares traded around $280 on Friday, in a 52-week range of $135.72 to $372.64.
PetroChina Co. Ltd. (NYSE: PTR) was upgraded to Buy from Neutral and its price target was raised to $61 from $37 at Goldman Sachs. The stock traded near $36 on Friday. The 52-week trading range is $27.68 to $41.20. Analysts have a consensus price target of $48.07.
Voyager Therapeutics, Inc. (NASDAQ: VYGR) was downgraded by Baird to Neutral from Outperform and its price target was cut to $6 from $18. The consensus price target is $11.55. Shares traded around $5.87 on Friday, in the 52-week range of $5.77 to $14.62.
Zynex Inc. (NASDAQ: ZYXI) was downgraded by B. Riley Securities to Neutral from Buy with a $19 price target. Early Friday, the stock traded near $14. The 52-week range is $7.93 to $29.73, and the consensus price target is $25.50.
See why short sellers pounced on Amazon and Apple but yielded on Facebook and electric vehicle makers. Also find out why investors have punished Plug Power.
Cathie Wood’s Ark Invest sold Pinterest, Snap and more, but what are the funds buying now?
The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.
Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.
A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.
Click here to learn how to get a quote in just a few minutes.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.